Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study
File(s)bmj.k934.full.pdf (282.71 KB)
Published version
Author(s)
Muller, DC
Tzoulaki, I
Lassale, CM
Riboli, E
Type
Journal Article
Abstract
Objective To investigate the association between alcohol consumption (at baseline and over lifetime) and non-fatal and fatal coronary heart disease (CHD) and stroke.
Design Multicentre case-cohort study.
Setting A study of cardiovascular disease (CVD) determinants within the European Prospective Investigation into Cancer and nutrition cohort (EPIC-CVD) from eight European countries.
Participants 32 549 participants without baseline CVD, comprised of incident CVD cases and a subcohort for comparison.
Main outcome measures Non-fatal and fatal CHD and stroke (including ischaemic and haemorrhagic stroke).
Results There were 9307 non-fatal CHD events, 1699 fatal CHD, 5855 non-fatal stroke, and 733 fatal stroke. Baseline alcohol intake was inversely associated with non-fatal CHD, with a hazard ratio of 0.94 (95% confidence interval 0.92 to 0.96) per 12 g/day higher intake. There was a J shaped association between baseline alcohol intake and risk of fatal CHD. The hazard ratios were 0.83 (0.70 to 0.98), 0.65 (0.53 to 0.81), and 0.82 (0.65 to 1.03) for categories 5.0-14.9 g/day, 15.0-29.9 g/day, and 30.0-59.9 g/day of total alcohol intake, respectively, compared with 0.1-4.9 g/day. In contrast, hazard ratios for non-fatal and fatal stroke risk were 1.04 (1.02 to 1.07), and 1.05 (0.98 to 1.13) per 12 g/day increase in baseline alcohol intake, respectively, including broadly similar findings for ischaemic and haemorrhagic stroke. Associations with cardiovascular outcomes were broadly similar with average lifetime alcohol consumption as for baseline alcohol intake, and across the eight countries studied. There was no strong evidence for interactions of alcohol consumption with smoking status on the risk of CVD events.
Conclusions Alcohol intake was inversely associated with non-fatal CHD risk but positively associated with the risk of different stroke subtypes. This highlights the opposing associations of alcohol intake with different CVD types and strengthens the evidence for policies to reduce alcohol consumption.
Design Multicentre case-cohort study.
Setting A study of cardiovascular disease (CVD) determinants within the European Prospective Investigation into Cancer and nutrition cohort (EPIC-CVD) from eight European countries.
Participants 32 549 participants without baseline CVD, comprised of incident CVD cases and a subcohort for comparison.
Main outcome measures Non-fatal and fatal CHD and stroke (including ischaemic and haemorrhagic stroke).
Results There were 9307 non-fatal CHD events, 1699 fatal CHD, 5855 non-fatal stroke, and 733 fatal stroke. Baseline alcohol intake was inversely associated with non-fatal CHD, with a hazard ratio of 0.94 (95% confidence interval 0.92 to 0.96) per 12 g/day higher intake. There was a J shaped association between baseline alcohol intake and risk of fatal CHD. The hazard ratios were 0.83 (0.70 to 0.98), 0.65 (0.53 to 0.81), and 0.82 (0.65 to 1.03) for categories 5.0-14.9 g/day, 15.0-29.9 g/day, and 30.0-59.9 g/day of total alcohol intake, respectively, compared with 0.1-4.9 g/day. In contrast, hazard ratios for non-fatal and fatal stroke risk were 1.04 (1.02 to 1.07), and 1.05 (0.98 to 1.13) per 12 g/day increase in baseline alcohol intake, respectively, including broadly similar findings for ischaemic and haemorrhagic stroke. Associations with cardiovascular outcomes were broadly similar with average lifetime alcohol consumption as for baseline alcohol intake, and across the eight countries studied. There was no strong evidence for interactions of alcohol consumption with smoking status on the risk of CVD events.
Conclusions Alcohol intake was inversely associated with non-fatal CHD risk but positively associated with the risk of different stroke subtypes. This highlights the opposing associations of alcohol intake with different CVD types and strengthens the evidence for policies to reduce alcohol consumption.
Date Issued
2018-05-29
Date Acceptance
2018-04-17
Citation
BMJ, 2018, 361 (1)
ISSN
0959-8138
Publisher
BMJ Publishing Group
Journal / Book Title
BMJ
Volume
361
Issue
1
Copyright Statement
© 2018 The Author(s). This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Identifier
https://www.bmj.com/content/361/bmj.k934
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
INDIVIDUAL-PARTICIPANT DATA
CAUSE-SPECIFIC MORTALITY
CARDIOVASCULAR-DISEASE
SMOKING-CESSATION
RISK-FACTORS
LIFE-STYLE
CONSUMPTION
METAANALYSIS
POLYPHENOLS
CANCER
Alcohol Drinking
Body Mass Index
Cause of Death
Coronary Artery Disease
Dose-Response Relationship, Drug
Endpoint Determination
Europe
Exercise
Female
Humans
Male
Middle Aged
Prospective Studies
Risk Reduction Behavior
Smoking
Stroke
Time Factors
Humans
Body Mass Index
Exercise
Endpoint Determination
Cause of Death
Prospective Studies
Alcohol Drinking
Smoking
Risk Reduction Behavior
Dose-Response Relationship, Drug
Time Factors
Middle Aged
Europe
Female
Male
Coronary Artery Disease
Stroke
General & Internal Medicine
1103 Clinical Sciences
1117 Public Health and Health Services
Publication Status
Published
Article Number
k934